Status:
COMPLETED
Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes
Lead Sponsor:
University of Cincinnati
Collaborating Sponsors:
Abbott
Jewish Hospital, Cincinnati, Ohio
Conditions:
Angina, Unstable
Eligibility:
All Genders
21+ years
Brief Summary
In a randomized, controlled clinical trial, point-of care testing at the bedside using the cardiac biomarker troponin I in ED patients with possible ACS will be compared to traditional testing of this...
Detailed Description
Cardiac troponin I is routinely used in the emergency department as a risk stratification tool for detecting myocardial necrosis in patients with possible acute coronary syndrome. It is our hypothesis...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Age \>21 years old
- Chest pain or other symptoms that lead to drawing cardiac bio-markers for possible ACS diagnosis
- Exclusion criteria
- Presentation with chest pain in the presence of a tachydysrhythmia (ventricular tachycardia, supraventricular tachycardia, or rapid atrial fibrillation)
- Presentation with ECG diagnostic for STEMI
Exclusion
Key Trial Info
Start Date :
December 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00222352
Start Date
December 1 2004
End Date
March 1 2007
Last Update
February 5 2018
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305-6203
2
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
3
The Jewish Hospital
Cincinnati, Ohio, United States, 45236
4
The University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104-6205